Iščem...
Iskalni niz je ali predolg ali pa vsebuje preveč besed.
Prevodi: en > sl
151–173/173
T/E
151 Prevajalska redakcija
izobraževanje
CELEX: 32002R0765
As described in: Sambrook, J., Fritsch, E.F., and Maniatis, T. (eds) in: Molecular Cloning, Cold Spring Harbour Laboratory Press (1989).
Kot je opisano v: Sambrook, J., Fritsch, E.F., and Maniatis, T. (eds): Molecular Cloning, Cold Spring Harbour Laboratory Press (1989).
152 Prevajalska redakcija
izobraževanje
CELEX: 31998L0098
Substances with specific effects on human health (see Chapter 4 of Annex VI) that are classified as carcinogenic, mutagenic and/or toxic for reproduction in categories 1 or 2 are ascribed Note E if they are also classified as very toxic (T+), toxic (T) or harmful (Xn).
K snovem s specifičnimi učinki na zdravje ljudi (glej poglavje 4 Priloge VI), ki so razvrščene kot rakotvorne, mutagene in/ali strupene za razmnoževanje v kategorijo 1 ali 2, se pripiše opomba E, če so razvrščene tudi kot zelo strupene (T+), strupene (T) ali zdravju škodljive (Xn).
153 Prevajalska redakcija
izobraževanje
CELEX: 31990L0630
Allow the 3 DH machine to slide rearward until a forward horizontal restraining load on the T-bar is no longer required i.e. until the seat pan contacts the seat-back.
3 DH-naprava se pusti drseti nazaj, dokler vodoravna, naprej usmerjena omejevalna obremenitev na T-drogu ni več potrebna, tj. dokler sedalo ne pride v stik z naslonom sedeža.
154 Prevajalska redakcija
izobraževanje
CELEX: 32000L0033
Botham, P.A., Hall, T.J., Dennett, R., McCall, J.C., Basketter, D.A., Whittle, E., Cheeseman, M., Esdaile, D.J. & Gardner, J. (1992), The skin corrosivity test in vitro:
Botham, P. A., Hall, T. J., Dennett, R., McCall, J. C., Basketter, D. A., Whittle, E., Cheeseman, M., Esdaile, D. J. & Gardner, J. (1992), The skin corrosivity test in vitro:
155 Prevajalska redakcija
izobraževanje
CELEX: 31990R2676
NMR spectrometer fitted with a specific 'deuterium' probe tuned to the characteristic frequency Vo of the field Bo (e.g. for Bo = 7,05 T, Vo = 46,05 MHz and for Bo = 9,4 T, Vo = 61,4 MHz) having a proton decoupling channel (B2) and field-frequency stabilization channel (lock) at the fluorine frequency.
NMR spektrometer, opremljen s specifično "devterijsko" sondo, nastavljeno na tipično frekvenco Vo polja Bo (npr. za Bo = 7,05 T, Vo = 46,05 MHz in za Bo = 9,4 T, Vo = 61,4 MHz), pri čemer sta kanal za ločevanje protonov (B2) in kanal za stabiliziranje frekvence polja (zavora) na frekvenci fluora.
156 Prevajalska redakcija
izobraževanje
CELEX: 32000L0032
Kier, L. D., Brusick D. J., Auletta, A. E., Von Halle, E. S., Brown, M. M., Simmon, V. F., Dunkel, V., McCann, J., Mortelmans, K., Prival, M., Rao, T. K. and Ray V. (1986), The Salmonella typhimurium/Mammalian Microsomal Assay: A Report of the U.S.
Kier, L. D., Brusick D. J., Auletta, A. E., Von Halle, E. S., Brown, M. M., Simmon, V. F., Dunkel, V., McCann, J., Mortelmans, K., Prival, M., Rao, T. K., in Ray V. (1986), The Salmonella typhimurium/Mammalian Microsomal Assay:
157 Prevajalska redakcija
izobraževanje
CELEX: 32003R0149
For a "CE" which performs multiple operations of a specific type in a single cycle (e.g., two additions per cycle or two identical logic operations per cycle), the execution time t is given by:
Pri "IE", ki izvaja večkratne operacije specifičnega tipa znotraj enega cikla (npr. dva seštevka na cikel ali dve enaki logični operaciji na cikel), se čas izvedbe t izračuna po formuli:
158 Prevajalska redakcija
izobraževanje
See, e.g. Commission Decision 94/893/EC in Case IV/M.430 - Procter & Gamble/VP Schickedanz (II), OJ L 354, 21.6.1994, p. 32, Case T-290/94, Kaysersberg v Commission, [1997] II-2137, paragraph 153;
Glej npr. Odločbo Komisije 94/893/ES v zadevi IV/M.430 - Procter & Gamble/VP Schickedanz (II), UL L 354, 21.6.1994, str. 32, zadevo T-290/94, Kaysersberg proti Komisiji, [1997] II-2137, odstavek 153;
159 Prevajalska redakcija
izobraževanje
CELEX: 32002D0657
See e.g. May, T.W., Brumbaugh, W.G., 1982, Matrix modifier and L'vov platform for elimination of matrix interferences in the analysis of fish tissues for lead by graphite furnace atomic absorption spectrometry:
Glej npr. May, T.W., Brumbaugh, W.G., Matrix modifier and L'vov platform for elimination of matrix interferences in the analysis of fish tissues for lead by graphite furnace atomic absorption spectrometry:
160 Prevajalska redakcija
RS
EMEA
Viraferon must be used cautiously in patients with debilitating medical conditions, such as those with a history of pulmonary disease (e. g., chronic obstructive pulmonary disease) or diabetes mellitus prone to t
Zdravilo Viraferon morate uporabljati previdno pri bolnikih z izčrpujočimi boleznimi in motnjami, npr. pri tistih s pljučno boleznijo v anamnezi (npr. kronična obstruktivna pljučna bolezen) ali sladkorna bolezen z on
161 Prevajalska redakcija
izobraževanje
CELEX: 32000L0032
Moore, M. M., Clive, D. Hozier, J. C., Howard, B. E., Batson, A. G., Turner, N. T. and Sawyer, J. (1985), Analysis of Trifluoronthymidine, Resistant (TFT+) Mutants of L5178Y/TK+/- - Mouse Lymphoma Cells, Mutation Res. 151, pp. 161-174.
Moore, M. M., Clive, D. Hozier, J. C., Howard, B. E., Batson, A. G., Turner, N. T., in Sawyer, J. (1985), Analysis of Trifluoronthymidine, Resistant (TFT+) Mutants of L5178Y/TK+/- - Mouse Lymphoma Cells, Mutation Res. 151, str. 161-174.
162 Prevajalska redakcija
RS
EMEA
• Put the cap back on the pen, with 0 next to the dosage indicator (picture E) • Check that the push-button is fully down. If it isn’ t, turn the cap until the push-button is fully depressed • Hold your Insulatard NovoLet horizontally.
• Ponovno namestite pokrov ek na peresnik, tako da je 0 na kazalniku odmerka (slika E). • Preverite, da je potisni gumb pritisnjen do konca. e ni, zasu ite pokrov ek, dokler ni potisni gumb povsem dol. • Držite Insulatard NovoLet vodoravno.
163 Prevajalska redakcija
RS
EMEA
• Put the cap back on the pen, with 0 next to the dosage indicator (picture E) • Check that the push-button is fully down. If it isn’ t, turn the cap until the push-button is fully depressed • Hold your Protaphane NovoLet horizontally.
• Ponovno namestite pokrov ek na peresnik, tako da je 0 na kazalniku odmerka (slika E). • Preverite, da je potisni gumb pritisnjen do konca. e ni, zasu ite pokrov ek, dokler ni potisni gumb povsem dol. • Držite Protaphane NovoLet vodoravno.
164 Prevajalska redakcija
RS
EMEA
The CVMP has assessed an experimental study on clinical efficacy of Methoxasol-T for treatment of a respiratory infection caused by E. coli in chickens, as well as bibliographic and pharmacovigilance data provided by the marketing authorisation holder.
CVMP je ocenil eksperimentalno študijo o klinični učinkovitosti zdravila Methoxasol- T pri zdravljenju okužbe dihal, ki jo povzroča E. coli pri piščancih, kakor tudi bibliografske in farmakovigilančne podatke, ki jih je predložil imetnik dovoljenja za promet z zdravilom.
165 Prevajalska redakcija
RS
EMEA
Premenopausal women with glucocorticoid-induced osteoporosis should be considered at high risk for fracture if they have a prevalent fracture or a combination of risk factors that place them at high risk for fracture (e. g., low bone density [ e. g., T score ≤− 2 ], sustained high dose glucocorticoid therapy [ e. g., ≥ 7.5 mg/ day for at least 6 months ], high underlying disease activity, low sex steroid levels).
Ženske pred menopavzo, ki imajo osteoporozo povzročeno z glukokortikoidi, se morajo obravnavati z visokim tveganjem za zlom, če imajo pogosto zlom ali kombinacijo dejavnikov tveganja, kar jih postavlja na mesto z visokim tveganjem za zlom (npr. nizka kostna gostota [ npr. T vrednost ≤ −2 ], podaljšani visoki odmerki glukokortikoidne terapije [ npr. ≥ 7, 5 mg/ dan za najmanj 6 mesecev ], visoko osnovno delovanje bolezni, nizki nivoji spolnega steroida).
166 Prevajalska redakcija
izobraževanje
CELEX: 32002R1360
T.Ident_Data A successful modification of identification data held by the TOE (e.g. the type of card, or the card expiry date or the cardholder identification data) would allow a fraudulent use of the TOE and would be a major threat to the global security objective of the system.
T.Ident_Data Uspešna sprememba identifikacijskih podatkov shranjenih v TOE (npr. vrste kartice, datuma izteka veljavnosti kartice, identifikacijskih podatkov imetnika kartice) bi lahko omogočila goljufivo uporabo TOE in bi pomenila veliko grožnjo skupnemu varnostnemu cilju sistema.
167 Prevajalska redakcija
RS
EMEA
Specifically, lenalidomide inhibits proliferation of certain haematopoietic tumour cells (including MM plasma tumour cells and those with deletions of chromosome 5), enhances T cell- and Natural Killer (NK) cell-mediated immunity and increases the number of NK T cells, inhibits angiogenesis by blocking the migration and adhesion of endothelial cells and the formation of microvessels, augments foetal haemoglobin production by CD34+ haematopoietic stem cells, and inhibits production of pro-inflammatory cytokines (e.g., TNF-α and IL-6) by monocytes.
Lenalidomid zavira proliferacijo nekaterih hematopoetskih tumorskih celic (vključno s tumorskimi celicami MM v plazmi in celicami z delecijo v kromosomu 5), okrepi celično imunost, ki jo posredujejo celice T in naravne ubijalke (NK - Natural Killer), ter poveča število celic NKT, zavira angiogenezo, tako da blokira migracijo in adhezijo endotelijskih celic in tvorbo mikrožil, izboljša fetalno sintezo hemoglobina v hematopoetskih zarodnih celicah CD34+ in zavira sintezo proinflamatornih citokinov (npr. TNF- α in IL- 6) v monocitih.
168 Prevajalska redakcija
RS
EMEA
An a-posteriori analysis was performed on a subgroup of patients from the TROPOS study of particular medical interest and at high-risk of fracture [ defined by a femoral neck BMD T-score ≤ - 3 SD (manufacturer’ s range corresponding to -2.4 SD using NHANES III) and an age ≥ 74 years (n=1,977, i. e. 40 % of the TROPOS study population) ].
Analizo a posteriori so izvedli tudi pri podskupini bolnic iz študije TROPOS, ki so bile zlasti medicinsko zanimive in imele veliko tveganje za zlome [ opredeljeno kot MKG vratu stegnenice vrednost T ≤ - 3 SD (izdelovalčev razpon je ustrezal - 2, 4 SD po merilih NHANES III – National Health and Nutrition Examination Survey III) in starost ≥ 74 let (n = 1977, se pravi 40 % populacije v študiji TROPOS) ].
169 Prevajalska redakcija
izobraževanje
CELEX: 32000L0032
Tice, R. R., Hayashi, M., MacGregaro, J. T., Anderson, D., Blakey, D. H., Holden, H. E., Kirsch-Volders, M., Oleson Jr., F. B., Pacchierotti, F., Preston, R. J., Romagna, F., Shimada, H., Sutou, S. and Vannier, B. (1994), Report from the Working Group on the in Vivo Mammalian Bone Marrow Chromosomal Aberration Test, Mutation Res., 312, pp. 305-312.
Tice, R. R., Hayashi, M., MacGregaro, J. T., Anderson, D., Blakey, D. H., Holden, H. E., Kirsch-Volders, M., Oleson Jr., F. B., Pacchierotti, F., Preston, R. J., Romagna, F., Shimada, H., Sutou, S., in Vannier, B. (1994), Report from the Working Group on the in Vivo Mammalian Bone Marrow Chromosomal Aberration Test, Mutation Res., 312, str. 305-312.
170 Prevajalska redakcija
izobraževanje
CELEX: 32003R1518
In section 22 of the licence, at least one of the following shall be indicated: - Restitución válida por [...] toneladas (cantidad por la que se expida el certificado) - Restitutionen omfatter [...] t (den mangde, licensen vedrorer) - Erstattung gültig für... Tonnen (Menge, für welche die Lizenz ausgestellt wurde) - >ISO_7>A?éóôniö? éó÷ýioóá aéá [...] ôüíioo (?ióüôçôá aéá ôçí i?ißá Ý÷aé aeäieaß ôi ?éóôi?iéçôéeü) - >ISO_1>Refund valid for... tonnes (quantity for which the licence is issued) - Restitution valable pour... tonnes (quantité pour laquelle le certificat est délivré) - Restituzione valida per [...] t (quantitativo per il quale il titolo e rilasciato)
V oddelku 22 dovoljenja se navede vsaj eno od naslednjega:
171 Prevajalska redakcija
izobraževanje
CELEX: 32003R1607
Fathur Rohman AL-GHOZHI (alias (a) Al Ghozi, Fathur Rohman, (b) Al Ghozi, Fathur Rahman, (c) Al-Gozi, Fathur Rohman, (d) Al-Gozi, Fathur Rahman, (e) Alghozi, Fathur Rohman, (f) Alghozi, Fathur Rahman, (g) Al-Gozhi, Fathur Rohman, (h) Al-Gozhi, Fathur Rahman, (i) Randy Alih, (j) Randy Ali, (k) Alih Randy, (l) Randy Adam Alih, (m) Sammy Sali Jamil, (n) Sammy Salih Jamil, (o) Rony Azad, (p) Rony Azad Bin Ahad, (q) Rony Azad Bin Ahmad, (r) Rony Azad Bin Amad, (s) Edris Anwar Rodin, (t) Abu Saad, (u) Abu Sa'ad, (v) Freedom Fighter);
Fathur Rohman AL-GHOZHI (alias (a) Al Ghozi, Fathur Rohman, (b) Al Ghozi, Fathur Rahman, (c) Al-Gozi, Fathur Rohman, (d) Al-Gozi, Fathur Rahman, (e) Alghozi, Fathur Rohman, (f) Alghozi, Fathur Rahman, (g) Al-Gozhi, Fathur Rohman, (h) Al-Gozhi, Fathur Rahman, (i) Randy Alih, (j) Randy Ali, (k) Alih Randy, (l) Randy Adam Alih, (m) Sammy Sali Jamil, (n) Sammy Salih Jamil, (o) Rony Azad, (p) Rony Azad Bin Ahad, (q) Rony Azad Bin Ahmad, (r) Rony Azad Bin Amad, (s) Edris Anwar Rodin, (t) Abu Saad, (u) Abu Sa'ad, (v) Freedom Fighter);
172 Prevajalska redakcija
izobraževanje
CELEX: 31994L0033
Substances and preparations classified according to Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (2) with amendments and Council Directive 88/379/EEC of 7 June 1988 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the classification, packaging and labelling of dangerous preparations (3) as toxic (T), very toxic (Tx), corrosive (C) or explosive (E);
Snovi in pripravki, razvrščeni skladno z Direktivo Sveta 67/548/EGS z dne 27. junija 1967 o približevanju zakonov in drugih predpisov v zvezi z razvrščanjem, pakiranjem in označevanjem nevarnih snovi [2] s spremembami ter Direktivo Sveta 88/379/EGS z dne 7. junija 1988 o približevanju zakonov in drugih predpisov držav članic v zvezi z razvrščanjem, pakiranjem in označevanjem nevarnih pripravkov [3] kot strupeni (T), zelo strupeni (Tx), korozivni (C) ali eksplozivni (E);
173 Prevajalska redakcija
RS
EMEA
Viral infection (e. g. influenza, herpes virus infection) Uncommon: Sepsis, tuberculosis, abscess, bacterial infection, fungal infection, cellulitis, candidiasis Unknown: Opportunistic infections (such as atypical mycobacterial infection, pneumocystosis, histoplasmosis, coccidioidomycosis, cryptococcosis, aspergillosis and listeriosis), hepatitis B reactivation, salmonellosis Neoplasms benign, malignant and unspecified (including cysts and polyps) Unknown: Hepatosplenic T-cell lymphoma (primarily in adolescents and young adults with Crohn’ s disease and ulcerative colitis), lymphoma (including non-Hodgkin’ s lymphoma and Hodgkin’ s disease) Blood and lymphatic system disorders Uncommon: Neutropenia, leukopenia, thrombocytopenia, anaemia, lymphopenia, lymphadenopathy, lymphocytosis Unknown: Agranulocytosis, thrombotic thrombocytopenic purpura, pancytopenia, haemolytic anaemia, idiopathic thrombocytopenic purpura Immune system disorders Common: Serum sickness-like reaction Uncommon: Anaphylactic reaction, lupus-like syndrome, allergic respiratory symptom Unknown: Anaphylactic shock, serum sickness, vasculitis Psychiatric disorders Uncommon: Depression, amnesia, agitation, confusion, insomnia, somnolence, nervousness, apathy Nervous system disorders Common: Headache, vertigo, dizziness Uncommon: Central nervous system demyelinating disorders (multiple sclerosis-like disease) Rare: Meningitis Unknown: Peripheral demyelinating disorders (such as Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy), central nervous system demyelinating disorders (such as optic neuritis), transverse myelitis, seizure, neuropathy, hypoaesthesia, paraesthesia Eye disorders Uncommon: Endophthalmitis, keratitis, conjunctivitis, periorbital oedema, hordeolum Cardiac disorders
Infekcijske in parazitske bolezni pogosti: virusne okužbe (npr. gripa ali herpesne okužbe) občasni: sepsa, tuberkuloza, absces, bakterijske okužbe, glivične okužbe, celulitis, kandidiaza neznana: oportunistične okužbe (npr. atipična mikobakterijska okužba, pnevmocistoza, histoplazmoza, kokcidioidomikoza, kriptokokoza, aspergiloza in listerioza), reaktivacija hepatitisa B, salmoneloza Benigne, maligne in neopredeljene neoplazme (vključno s cistami in polipi) neznana: hepatosplenični limfom T celic (primarno pri mladostnikih in mlajših odraslih s Crohnovo boleznijo in ulceroznim kolitisom), limfom (vključno z neHodgkinovim limfomom in Hodgkinovo boleznijo) Bolezni krvi in limfatičnega sistema občasni: nevtropenija, levkopenija, trombocitopenija, anemija, limfopenija, limfadenopatija, limfocitoza neznana: agranulocitoza, trombotična trombocitopenična purpura, pancitopenija, hemolitična anemija, idiopatska trombocitopenična purpura Bolezni imunskega sistema pogosti: reakcije, podobne serumski bolezni občasni: anafilaktične reakcije, lupusu podoben sindrom, alergijski simptomi v dihalih neznana: anafilaktični šok, serumska bolezen, vaskulitis Psihiatrične motnje občasni: depresija, amnezija, vznemirjenost, zmedenost, nespečnost, zaspanost, živčnost, apatija Bolezni živčevja pogosti: glavobol, vrtoglavica, omotica občasni: demielinizirajoče motnje osrednjega živčevja (bolezen, podobna multipli sklerozi) redki: meningitis
Prevodi: en > sl
151–173/173
T/E